SPOTLIGHT -
Atlanta-CIBA Vision is making its Focus Night & Day lenses available for therapeutic use following approvals by the FDA and Health Canada.
Multiple companies announce data presentations at ARVO 2024
(EyePod) From idea to impact: Navigating ophthalmic innovation
Eyenovia provides clinical, scientific update on FDA-approved products Mydcombi and clobetasol propionate ophthalmic suspension
EyePod: Modifier Gene Therapy: What is it?
Gene editing untangles one strand of the AMD web
Phoenix-Micron Inc and ArtiKode Intelligence team up to enhance OCT imaging with AI